Concentrations |
3 Months Ended | 12 Months Ended |
|---|---|---|
Mar. 31, 2025 |
Dec. 31, 2024 |
|
| Concentrations [Abstract] | ||
| CONCENTRATIONS | NOTE 6 – CONCENTRATIONS
Customer concentration
For the three months ended March 31, 2025 and 2024, one licensee accounted for 100% total revenues from customer license fees.
Vendor concentrations
For the three months ended March 31, 2025 and 2024, one licensor accounted for 100% of the Company’s vendor license agreements (see Note 7) related to the Company’s biopharmaceutical operations. |
NOTE 7 – CONCENTRATIONS
Customer concentration
For the years ended December 31, 2024 and 2023, one licensee accounted for 100% total revenues from customer license fees.
Vendor concentrations
For the years ended December 31, 2024 and 2023, one licensor accounted for 100% of the Company’s vendor license agreements (see below) related to the Company’s biopharmaceutical operations. |